ALZCUR — AlzeCure Pharma AB Balance Sheet
0.000.00%
Last trade - 00:00
- SEK179.74m
- SEK160.70m
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 182 | 112 | 41.7 | 25.6 | 29.1 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 1.93 | 3.06 | 1.54 | 1.38 | 1.47 |
Prepaid Expenses | |||||
Total Current Assets | 185 | 116 | 44.2 | 27.5 | 31.6 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 1.77 | 1.94 | 1.42 | 0.852 | 0.376 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 187 | 118 | 45.6 | 70.8 | 32 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 4.75 | 7.07 | 12.7 | 10.4 | 8.23 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 4.75 | 7.07 | 12.7 | 10.4 | 8.23 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 182 | 111 | 33 | 60.5 | 23.8 |
Total Liabilities & Shareholders' Equity | 187 | 118 | 45.6 | 70.8 | 32 |
Total Common Shares Outstanding |